Silencing of IFN-β by siRNA or addition of purified IFN-β (see Fig. 2D) had a large effect on MHC class I expression, suggesting a causal relationship between elevated IFN-β signaling and increased MHC I expression in TPT-treated breast cancer cells. This evidence concerns the gene IFNB1 and breast carcinoma.